Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Pharmdca Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1884013189.png) Pharmdca [@Pharmdca](/creator/twitter/Pharmdca) on x 126.6K followers
Created: 2022-04-04 13:25:10 UTC

$CRVS
Recent insider buying including CEO and CFO.
CEO Dr. Richard Miller, founder of $PCYC ($21Billion acquisition) received 2020 Drug Hunter Award. 
CEO previous successes with Rituximab and Imbruvica.
Possibility of partnership or deal in future for their anti-CD73 drug.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1510971743476727815/c:line.svg)

**Related Topics**
[acquisition](/topic/acquisition)
[$21billion](/topic/$21billion)
[$pcyc](/topic/$pcyc)
[insider](/topic/insider)
[$crvs](/topic/$crvs)
[pharmdca](/topic/pharmdca)

[Post Link](https://x.com/Pharmdca/status/1510971743476727815)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Pharmdca Avatar Pharmdca @Pharmdca on x 126.6K followers Created: 2022-04-04 13:25:10 UTC

$CRVS Recent insider buying including CEO and CFO. CEO Dr. Richard Miller, founder of $PCYC ($21Billion acquisition) received 2020 Drug Hunter Award. CEO previous successes with Rituximab and Imbruvica. Possibility of partnership or deal in future for their anti-CD73 drug.

XX engagements

Engagements Line Chart

Related Topics acquisition $21billion $pcyc insider $crvs pharmdca

Post Link

post/tweet::1510971743476727815
/post/tweet::1510971743476727815